abstract |
The present invention relates to novel 7,9-substituted tetracycline compounds. These tetracycline compounds treat many tetracycline compound responsive conditions such as bacterial infections and neoplasms, other known uses of common minocyclines such as blocking tetracycline excretion, and gene expression. It can also be used for applications such as adjustment. |